SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
193 hedge funds and large institutions have $1.21B invested in Sage Therapeutics in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 83 increasing their positions, 44 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
-30
Holders Change %
-13.45%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
83
Reduced
44
Closed
59
Calls
$19.5M
Puts
$8.57M
Net Calls
+$11M
Net Calls Change
+$6M
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$106M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$90.1M |
| 3 |
SC
3
Samlyn Capital
New York
|
$15.2M |
| 4 |
4
Alyeska Investment Group
Chicago,
Illinois
|
$10.9M |
| 5 |
5
Morgan Stanley
New York
|
$17.8M |
